Guangdong Marubi Biotechnology Co Ltd
SSE:603983
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
20.56
36.17
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Guangdong Marubi Biotechnology Co Ltd
Free Cash Flow
Guangdong Marubi Biotechnology Co Ltd
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
Guangdong Marubi Biotechnology Co Ltd
SSE:603983
|
Free Cash Flow
¥30.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-44%
|
CAGR 10-Years
N/A
|
|
|
Hengan International Group Company Ltd
HKEX:1044
|
Free Cash Flow
¥1.9B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
0%
|
|
|
S
|
Shanghai Flyco Electrical Appliance Co Ltd
SSE:603868
|
Free Cash Flow
¥333.2m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
|
Proya Cosmetics Co Ltd
SSE:603605
|
Free Cash Flow
¥887.6m
|
CAGR 3-Years
39%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
By-health Co Ltd
SZSE:300146
|
Free Cash Flow
¥794.1m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
G
|
Giant Biogene Holding Co Ltd
HKEX:2367
|
Free Cash Flow
¥1.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Guangdong Marubi Biotechnology Co Ltd
Glance View
Guangdong Marubi Biotechnology Co Ltd stands as a compelling narrative of innovation and heritage in the realm of beauty and skincare. Established in 2002, the company has carved a niche in China’s competitive cosmetics industry by blending advanced biotechnology with traditional skincare practices. This fusion forms the backbone of Marubi’s product portfolio, which spans an array of skincare solutions including anti-aging serums, hydrating masks, and rejuvenating creams. The company’s strength lies in its robust research and development framework, where scientific rigor meets the potential of natural ingredients, leading to the formulation of effective skincare products. By fostering partnerships with renowned research institutions, Marubi ensures that its offerings are not only well-aligned with consumer expectations but also backed by solid scientific evidence. In the financial landscape, Marubi’s operational model is keenly focused on understanding consumer trends and leveraging digital marketing strategies to solidify its market position. A significant portion of the company’s revenues is generated through e-commerce platforms, which tap into China’s rapidly growing online retail market. Emphasizing brand loyalty and customer engagement, Marubi has utilized social media and collaborations with influencers to promote its products and extend its reach beyond traditional retail channels. Moreover, the company has established a keen presence in offline sales, ensuring its brand stands out in both bustling urban centers and emerging local markets. Through this strategic synergy between online and offline sales avenues, Guangdong Marubi Biotechnology Co Ltd thrives as a modern skincare powerhouse, creating value continuously in an ever-evolving market landscape.
See Also
What is Guangdong Marubi Biotechnology Co Ltd's Free Cash Flow?
Free Cash Flow
30.1m
CNY
Based on the financial report for Sep 30, 2024, Guangdong Marubi Biotechnology Co Ltd's Free Cash Flow amounts to 30.1m CNY.
What is Guangdong Marubi Biotechnology Co Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-44%
You don't have any saved screeners yet
